Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 1;7(5):e249429.
doi: 10.1001/jamanetworkopen.2024.9429.

Medically Assisted Reproduction and Risk of Cancer Among Offspring

Paula Rios  1   2 , Philippe Herlemont  1 , Patricia Fauque  3 , Brigitte Lacour  2   4   5 , Pierre Jouannet  6 , Alain Weill  1 , Mahmoud Zureik  1 , Jacqueline Clavel  2   4   5 , Rosemary Dray-Spira  1
Affiliations

Medically Assisted Reproduction and Risk of Cancer Among Offspring

Paula Rios et al. JAMA Netw Open. .

Abstract

Importance: Cancer is a leading cause of death among children worldwide. Treatments used for medically assisted reproduction (MAR) are suspected risk factors because of their potential for epigenetic disturbance and associated congenital malformations.

Objective: To assess the risk of cancer, overall and by cancer type, among children born after MAR compared with children conceived naturally.

Design, setting, and participants: For this cohort study, the French National Mother-Child Register (EPI-MERES) was searched for all live births that occurred in France between January 1, 2010, and December 31, 2021 (and followed up until June 30, 2022). The EPI-MERES was built from comprehensive data of the French National Health Data System. Data analysis was performed from December 1, 2021, to June 30, 2023.

Exposure: Use of assisted reproduction technologies (ART), such as fresh embryo transfer (ET) or frozen ET (FET), and artificial insemination (AI).

Main outcomes and measures: The risk of cancer was compared, overall and by cancer type, among children born after fresh ET, FET, or AI and children conceived naturally, using Cox proportional hazards regression models adjusted for maternal and child characteristics at birth.

Results: This study included 8 526 306 children with a mean (SD) age of 6.4 (3.4) years; 51.2% were boys, 96.4% were singletons, 12.1% were small for gestational age at birth, and 3.1% had a congenital malformation. There were 260 236 children (3.1%) born after MAR, including 133 965 (1.6%) after fresh ET, 66 165 (0.8%) after FET, and 60 106 (0.7%) after AI. A total of 9256 case patients with cancer were identified over a median follow-up of 6.7 (IQR, 3.7-9.6) years; 165, 57, and 70 were born after fresh ET, FET, and AI, respectively. The overall risk of cancer did not differ between children conceived naturally and those born after fresh ET (hazard ratio [HR], 1.12 [95% CI, 0.96 to 1.31]), FET (HR, 1.02 [95% CI, 0.78 to 1.32]), or AI (HR, 1.09 [95% CI, 0.86 to 1.38]). However, the risk of acute lymphoblastic leukemia was higher among children born after FET (20 case patients; HR 1.61 [95% CI, 1.04 to 2.50]; risk difference [RD], 23.2 [95% CI, 1.5 to 57.0] per million person-years) compared with children conceived naturally. Moreover, among children born between 2010 and 2015, the risk of leukemia was higher among children born after fresh ET (45 case patients; HR, 1.42 [95% CI, 1.06 to 1.92]; adjusted RD, 19.7 [95% CI, 2.8 to 43.2] per million person-years).

Conclusions and relevance: The findings of this cohort study suggest that children born after FET or fresh ET had an increased risk of leukemia compared with children conceived naturally. This risk, although resulting in a limited number of cases, needs to be monitored in view of the continuous increase in the use of ART.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Rios received grant funding from the French National Agency for Medicines and Health Products Safety during the conduct of the study. No other disclosures were reported.

Figures

Figure.
Figure.. Children Born in France Between 2010 and 2021 After Medically Assisted Reproduction
See this image and copyright information in PMC

Comment in

References

    1. Lacour B, Guyot-Goubin A, Guissou S, Bellec S, Désandes E, Clavel J. Incidence of childhood cancer in France: national children cancer registries, 2000-2004. Eur J Cancer Prev. 2010;19(3):173-181. doi: 10.1097/CEJ.0b013e32833876c0 - DOI - PubMed
    1. Marshall GM, Carter DR, Cheung BB, et al. The prenatal origins of cancer. Nat Rev Cancer. 2014;14(4):277-289. doi: 10.1038/nrc3679 - DOI - PMC - PubMed
    1. Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. ; International Committee for Monitoring Assisted Reproductive Technology; World Health Organization . International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009;92(5):1520-1524. doi: 10.1016/j.fertnstert.2009.09.009 - DOI - PubMed
    1. Raimondi S, Pedotti P, Taioli E. Meta-analysis of cancer incidence in children born after assisted reproductive technologies. Br J Cancer. 2005;93(9):1053-1056. doi: 10.1038/sj.bjc.6602838 - DOI - PMC - PubMed
    1. Hargreave M, Jensen A, Toender A, Andersen KK, Kjaer SK. Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril. 2013;100(1):150-161. doi: 10.1016/j.fertnstert.2013.03.017 - DOI - PubMed

Publication types